Latest filing published 22 Jan 2008 for Gabelli Healthcare & WellnessRx Trust, €10k.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -29.6%Entry US$6.38 · Close at T+365 US$4.49
- -26.6%Entry US$6.01 · Close at T+365 US$4.41
- -29.3%Entry US$6.50 · Close at T+365 US$4.60
- -17.8%Entry US$19.34 · Close at T+365 US$15.89
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James E. Mckee: trading record in brief
This profile gathers the share dealings of James E. Mckee across 3 companies, led by Gamco Investors, INC. et AL, Gabelli Healthcare & WellnessRx Trust and Gabelli Dividend & Income Trust. Over a trading history stretching from 1 June 2006 to 17 January 2008, the count stands at 10 filings.
On the market, this insider has only ever bought: 4 purchases, €42k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. In 2008 alone, the filings show 3 purchases and no sales.
Half of the purchases are above €6,244 and half below. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 25% of cases, with a median move of -2.5%. This is a record of the past, not a forecast.
The latest filing, published on 22 January 2008, reports an open-market purchase of €10k in Gabelli Healthcare & WellnessRx Trust. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James E. Mckee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,200 shares@ US$6.77Common SharesSEC:0001271163-08-000005:0Canonical exit: 16 Apr 2008 (T+90)
- 500 shares@ US$6.79Common SharesSEC:0001271163-08-000004:0Canonical exit: 15 Apr 2008 (T+90)
- 400 shares@ US$6.75Common SharesSEC:0001271163-08-000003:0Canonical exit: 6 Apr 2008 (T+90)
- 6,000 sharesClass A Common StockSEC:0000807249-07-000419:0
- 2,000 shares@ US$18.49Common StockSEC:0001271163-07-000009:0Canonical exit: 14 Nov 2007 (T+90)
- 2 shares0Common SharesSEC:0001271319-07-000052:0
- 2,470 sharesClass B Common StockSEC:0000807249-06-000321:0
- 2,470 sharesClass B Common StockSEC:0000807249-06-000179:0
- 2,470 sharesClass B Common StockSEC:0000807249-06-000179:1
- 2,470 sharesClass B Common StockSEC:0000807249-06-000168:0
10 of 10 declarations
